Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will feature the latest advancements in Orthopaedic ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will feature the latest advancements in Orthopaedic Reconstruction at the American Academy of Orthopaedic Sur ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce that the latest annual report from the Australian ...
Smith+Nephew offers a highly personalized approach for both surgeons and their patients. CORIOGRAPH’s recent addition of support for hip procedures expands the platform’s reach to provide ...
new short stem hip—should help the firm weather headwinds from China. The bottom line: With Smith & Nephew hitting our full-year estimates nearly on the nose, we're leaving our $38/GBX 1,464 per ...
Analyst Adam Vettese of eToro said that "there were three cheers due for Smith and Nephew’s hip and knee replacement business over in the US, which was the main driver of growth." He added that ...
Profits at hip replacement making giant Smith & Nephew have jumped after a rebound in its US business. The medical technology giant, which is listed on the FTSE 100, has been in the midst of a ...
Profits at hip replacement making giant Smith & Nephew have jumped after a rebound in its US business. The medical technology giant, which is listed on the FTSE 100, has been in the midst of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results